Lessons from the cat: development of vaccines against lentiviruses (Q34522387)

2 August 2017

1 reference

title

Lessons from the cat: development of vaccines against lentiviruses (English)

1 reference

2 August 2017

Stephen P Dunham

1

1 reference

2 August 2017

publication date

5 May 2006

1 reference

Veterinary Immunology and Immunopathology

2 August 2017

published in

1 reference

2 August 2017

volume

112

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

67-77

1 reference

Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Vaginal and rectal infection of cats with feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Transmission and immunopathogenesis of FIV in cats as a model for HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Transmission of feline immunodeficiency virus from mother to kitten

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Clinical and pathological findings in feline immunodeficiency virus experimental infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Is an effective HIV vaccine feasible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Accuracy of polymerase chain reaction assays for diagnosis of feline immunodeficiency virus infection in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

HIV preferentially infects HIV-specific CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Characterization of two monoclonal antibodies against feline immunodeficiency virus gag gene products and their application in an assay to evaluate neutralizing antibody activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Enhancement after feline immunodeficiency virus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

In vivo functions of the auxiliary genes and regulatory elements of feline immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

The genome of feline immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Bold attitude makes male urban feral domestic cats more vulnerable to Feline Immunodeficiency Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

The immunology of HIV-infected long-term non-progressors--a current view.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Lymphoid activation: a confounding factor in AIDS vaccine development?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Use of CD134 as a primary receptor by the feline immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Phylogenetic analysis of feline immunodeficiency virus in Central Europe: a prerequisite for vaccination and molecular diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Anti-cell antibody in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

FIV infection of the domestic cat: an animal model for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Common mechanism of infection by lentiviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Experimental vaccine protection against feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

7 January 2021

Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

7 January 2021

Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

7 January 2021

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.03.013

7 January 2021

10.1016/J.VETIMM.2006.03.013

Identifiers

DOI

1 reference

2 August 2017

1 reference